Close Menu

xTAG

Luminex is developing an automated, handheld, battery-powered diagnostic system based on its xMAP technology to administer both molecular and immunoassays to help diagnose soldiers or provide biosurveillance data at the point of need, the company said this week.

Luminex CEO Patrick Balthrop said this week that the company is "well into the alpha stage" of development for its high-volume, low-multiplex, cartridge-based clinical diagnostic system, dubbed Project Aries.

The US Food and Drug Administration has cleared Luminex's xTAG Gastrointestinal Pathogen Panel for use on the firm's benchtop MagPix instrument.

For Luminex, 2013 is shaping up to be a year of molecular diagnostics menu expansion, instrument placements, and platform development.

This article has been updated from a version posted Jan. 10 to reflect the fact that Luminex has gained clearance for its gastrointestinal panel.

Luminex this week provided investors with additional details regarding the planned expansion of its molecular diagnostics business to tap into the laboratory-developed test market and to serve customers seeking a platform with higher throughput and lower multiplexing than Luminex

Luminex this week provided investors with an update on its molecular diagnostics pipeline, including the integration of recently acquired GenturaDx and its sample-to-answer testing platform and the market uptake and opportunity for its xTAG Gastrointestinal Pathogen Panel.

Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.

The firm received FDA clearance for an improved version of its multiplex CF test.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.